190 related articles for article (PubMed ID: 30726226)
1. PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
Mitchell KA; Moore JX; Rosenson RS; Irvin R; Guirgis FW; Shapiro N; Safford M; Wang HE
PLoS One; 2019; 14(2):e0210808. PubMed ID: 30726226
[TBL] [Abstract][Full Text] [Related]
2. PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).
Mefford MT; Rosenson RS; Cushman M; Farkouh ME; McClure LA; Wadley VG; Irvin MR; Bittner V; Safford MM; Somaratne R; Monda KL; Muntner P; Levitan EB
Circulation; 2018 Mar; 137(12):1260-1269. PubMed ID: 29146683
[TBL] [Abstract][Full Text] [Related]
3.
Kent ST; Rosenson RS; Avery CL; Chen YI; Correa A; Cummings SR; Cupples LA; Cushman M; Evans DS; Gudnason V; Harris TB; Howard G; Irvin MR; Judd SE; Jukema JW; Lange L; Levitan EB; Li X; Liu Y; Post WS; Postmus I; Psaty BM; Rotter JI; Safford MM; Sitlani CM; Smith AV; Stewart JD; Trompet S; Sun F; Vasan RS; Woolley JM; Whitsel EA; Wiggins KL; Wilson JG; Muntner P
Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
[TBL] [Abstract][Full Text] [Related]
4. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
Genga KR; Lo C; Cirstea MS; Leitao Filho FS; Walley KR; Russell JA; Linder A; Francis GA; Boyd JH
EBioMedicine; 2018 Dec; 38():257-264. PubMed ID: 30473376
[TBL] [Abstract][Full Text] [Related]
5. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1.
Atreya MR; Cvijanovich NZ; Fitzgerald JC; Weiss SL; Bigham MT; Jain PN; Schwarz AJ; Lutfi R; Nowak J; Allen GL; Thomas NJ; Grunwell JR; Baines T; Quasney M; Haileselassie B; Alder MN; Lahni P; Ripberger S; Ekunwe A; Campbell KR; Walley KR; Standage SW
Crit Care; 2023 Jun; 27(1):250. PubMed ID: 37365661
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.
Mefford MT; Marcovina SM; Bittner V; Cushman M; Brown TM; Farkouh ME; Tsimikas S; Monda KL; López JAG; Muntner P; Rosenson RS
J Lipid Res; 2019 Nov; 60(11):1946-1952. PubMed ID: 31511398
[TBL] [Abstract][Full Text] [Related]
7. A Genetic Approach to the Association Between PCSK9 and Sepsis.
Feng Q; Wei WQ; Chaugai S; Carranza Leon BG; Kawai V; Carranza Leon DA; Jiang L; Zhong X; Liu G; Ihegword A; Shaffer CM; Linton MF; Chung CP; Stein CM
JAMA Netw Open; 2019 Sep; 2(9):e1911130. PubMed ID: 31509211
[TBL] [Abstract][Full Text] [Related]
8. The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.
Ooi TC; Krysa JA; Chaker S; Abujrad H; Mayne J; Henry K; Cousins M; Raymond A; Favreau C; Taljaard M; Chrétien M; Mbikay M; Proctor SD; Vine DF
J Clin Endocrinol Metab; 2017 Sep; 102(9):3452-3460. PubMed ID: 28673045
[TBL] [Abstract][Full Text] [Related]
9. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock.
Atreya MR; Whitacre BE; Cvijanovich NZ; Bigham MT; Thomas NJ; Schwarz AJ; Weiss SL; Fitzgerald JC; Allen GL; Lutfi R; Nowak JE; Quasney MW; Shah AS; Wong HR
Crit Care Med; 2020 Oct; 48(10):1513-1520. PubMed ID: 32769621
[TBL] [Abstract][Full Text] [Related]
10. Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration.
Wanneh E; Luna G; Dufour R; Baass A
J Clin Lipidol; 2017; 11(1):55-60. PubMed ID: 28391911
[TBL] [Abstract][Full Text] [Related]
11. PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.
Holmes MV; Kartsonaki C; Boxall R; Lin K; Reeve N; Yu C; Lv J; Bennett DA; Hill MR; Yang L; Chen Y; Du H; Turnbull I; Collins R; Clarke RJ; Tobin MD; Li L; Millwood IY; Chen Z; Walters RG;
Eur J Prev Cardiol; 2024 Jun; 31(8):1015-1025. PubMed ID: 38198221
[TBL] [Abstract][Full Text] [Related]
12. The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.
Feng Q; Wei WQ; Chung CP; Levinson RT; Bastarache L; Denny JC; Stein CM
Pharmacogenomics J; 2017 Mar; 17(2):204-208. PubMed ID: 26902539
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol levels and long-term rates of community-acquired sepsis.
Guirgis FW; Donnelly JP; Dodani S; Howard G; Safford MM; Levitan EB; Wang HE
Crit Care; 2016 Dec; 20(1):408. PubMed ID: 28010729
[TBL] [Abstract][Full Text] [Related]
14. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
[TBL] [Abstract][Full Text] [Related]
15. Black-white racial disparities in sepsis: a prospective analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
Moore JX; Donnelly JP; Griffin R; Safford MM; Howard G; Baddley J; Wang HE
Crit Care; 2015 Jul; 19(1):279. PubMed ID: 26159891
[TBL] [Abstract][Full Text] [Related]
16. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
[TBL] [Abstract][Full Text] [Related]
17. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
Ference BA; Robinson JG; Brook RD; Catapano AL; Chapman MJ; Neff DR; Voros S; Giugliano RP; Davey Smith G; Fazio S; Sabatine MS
N Engl J Med; 2016 Dec; 375(22):2144-2153. PubMed ID: 27959767
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Mediterranean-style diet and risk of sepsis in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
Gray MS; Wang HE; Martin KD; Donnelly JP; Gutiérrez OM; Shikany JM; Judd SE
Br J Nutr; 2018 Dec; 120(12):1415-1421. PubMed ID: 30375291
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained.
Lebeau P; Platko K; Al-Hashimi AA; Byun JH; Lhoták Š; Holzapfel N; Gyulay G; Igdoura SA; Cool DR; Trigatti B; Seidah NG; Austin RC
J Biol Chem; 2018 May; 293(19):7329-7343. PubMed ID: 29593095
[TBL] [Abstract][Full Text] [Related]
20. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
